{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:59:50Z","timestamp":1790805590971,"version":"4.1.0"},"reference-count":26,"publisher":"Index Copernicus","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pol Przegl Chir"],"published-print":{"date-parts":[[2017,2,28]]},"abstract":"<jats:p>Diverticulosis, its associated symptoms and complications are one of the most common pathologies of the gastrointestinal tract in more economically developed countries. Presence of diverticuli and their clinical consequences can be divided into four categories: 1) diverticulosis, i.e. an asymptomatic presence of diverticuli that are usually found by accident 2) symptomatic uncomplicated diverticulosis 3) diverticulitis (acute uncomplicated diverticulitis) 4) complications of diverticulitis (conditions requiring hospital stay). The aim of this study was to retrospectively analyze the efficacy of rifaximin in preventing diverticulitis in patients visiting proctology clinics. The diagnostic criterium for diverticulosis was confirmation by colonoscopy, barium enema or CT colography (virtual colonoscopy) as well as history of at least one documented episode of diverticulosis. History of diverticulosis was evaluated based on medical records, clinical symptoms, elevated level of CRP (&gt;5.0) and\/or diagnostic imaging (ultrasound, CT). After setting strict exclusion criteria, 248 patients were qualified for the study out of 686, and they were later divided into two groups: control group (group I \u2013 145 patients) and studied group (group II \u2013 103 patients receiving rifaximin prophylaxis). Diverticulitis rate was comparable in both groups over a period of 6 months before study (p = 0.1306) and 6 months of treatment (p=0.3044). Between the 6th and 12th month of treatment, a significantly lower rate of diverticulitis was noted in the group receiving rifaximin compared to control group (p&lt;0.0001). Patients receiving rifaximin reported higher quality of life (which was assessed using the VAS scale) compared to control group after 12 months. The results confirmed the efficacy of riaximin in prevention of diverticulitis, even in the scheme of repeated courses every 3 months. Not only did application of rifaximin lower the rate of diverticulitis and its complications in patients after an episode of diverticulitis, but also it improved the patients\u2019 quality of life. It seems that diverticulitis prophylaxis based on rifaximin can be economically efficient, however, it requires further research.<\/jats:p>","DOI":"10.5604\/01.3001.0009.6012","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T05:19:48Z","timestamp":1526966388000},"page":"22-31","source":"Crossref","is-referenced-by-count":11,"title":["The influence of rifaximin on diverticulitis rate and quality of life in patients with diverticulosis"],"prefix":"10.5604","volume":"89","author":[{"given":"Tomasz","family":"Banasiewicz","sequence":"first","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu Pa\u0144stwowa Wy\u017csza Szko\u0142a Zawodowa im. Prezydenta Stanis\u0142awa Wojciechowskiego w Kaliszu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Francuzik","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Dermatologie, Venerologie und Allergologie; Charit\u00e9 Universit\u00e4tsmedzin Berlin, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bobkiewicz","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Krokowicz","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Borejsza-Wysocki","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Paszkowski","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Studniarek","sequence":"additional","affiliation":[{"name":"Department of General Surgery Rutgers New Jersey Medical School, Newark, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Krokowicz","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej i Kolorektalnej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Grochowalski","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej i Kolorektalnej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Zastawna","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Szczepkowski","sequence":"additional","affiliation":[{"name":"Kliniczny Oddzia\u0142 Chirurgii Og\u00f3lnej i Kolorektalnej Szpitala Biela\u0144skiego w Warszawie Wydzia\u0142 Rehabilitacji Akademii Wychowania Fizycznego J\u00f3zefa Pi\u0142sudskiego w Warszawie"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Lorenc","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej, Kolorektalnej i Urazowej, Szpital \u015aw. Barbary w Sosnowcu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Drews","sequence":"additional","affiliation":[{"name":"Klinika Chirurgii Og\u00f3lnej, Endokrynologicznej i Onkologii Gastroenterologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3689","reference":[{"key":"140663r1","unstructured":"Yamada E., Inamori M., Uchida E., Tanida E., Izumi M., Takeshita K. et al.:Association between the location of diverticular disease and the irritablebowel syndrome: a\u00a0multicenter study in Japan. Am. J. Gastroenterol. 2014;109: 1900\u20131905."},{"key":"140663r2","doi-asserted-by":"crossref","unstructured":"Strate L., Erichsen R., Baron J., Mortensen J., Pedersen J., Riis A. et al.:Heritabilityand familial aggregation of diverticular disease: a\u00a0population-basedstudy of twins and siblings. Gastroenterology. 2013; 144: 736\u2013742.","DOI":"10.1053\/j.gastro.2012.12.030"},{"key":"140663r3","doi-asserted-by":"crossref","unstructured":"Tursi A.: Diverticulosis today: unfashionable and still under-researched.Therap. Adv. Gastroenterol. 2016 Mar.; 9 (2): 213\u2013228. doi:10.1177\/1756283X15621228","DOI":"10.1177\/1756283X15621228"},{"key":"140663r4","unstructured":"Pietrzak A., Bartnik W., Szczepkowski M., Krokowicz P., Dziki A., Regu\u0142a J., WallnerG.: Polski konsensus interdyscyplinarny dotycz\u0105cy diagnostyki i\u00a0leczeniachoroby uchy\u0142owej okr\u0119\u017cnicy. Gastroenterologia Kliniczna. 2015; 7, 1, 1\u201319."},{"key":"140663r5","doi-asserted-by":"crossref","unstructured":"Pietrzak A., Bartnik W., Szczepkowski M., Krokowicz P., Dziki A., Regu\u0142aJ., Wallner G.: Polish interdisciplinary consensus on diagnostics and treatmentof colonic diverticulosis. Pol. Przegl. Chir. 2015 Apr.; 87 (4): 203\u2013220.doi: 10.1515\/pjs-2015-0045.","DOI":"10.1515\/pjs-2015-0045"},{"key":"140663r6","doi-asserted-by":"crossref","unstructured":"Simpson J., Neal K.R., Scholefield J.H., Spiller R.C.: Patterns of pain in diverticulardisease and influence of acute diverticulitis. Eur. J. Gastroenterol.Hepatol. 2003; 15: 1005\u22121010.","DOI":"10.1097\/00042737-200309000-00011"},{"key":"140663r7","doi-asserted-by":"crossref","unstructured":"Sopena F., Lanas A.: Management of colonic diverticular disease with poorlyabsorbed antibiotics and other therapies. Ther. Adv. Gastroenterol. 2011;4: 365\u2212374.","DOI":"10.1177\/1756283X11412820"},{"key":"140663r8","unstructured":"Pietrzak A.: Leczenie zapalenia uchy\u0142k\u00f3w \u2013 punkt widzenia gastroenterologa.Gastroenterologia Praktyczna. 2016 (VIII): 9\u201313."},{"key":"140663r9","doi-asserted-by":"crossref","unstructured":"Lahner E., Bellisario C., Hassan C., Zullo A., Esposito G., Annibale B.: Probioticsin the treatment of diverticular disease. A\u00a0systematic review. J. Gastrointestin.Liver. Dis. 2016 Mar.; 25(1):79\u221286. doi: 10.15403\/jgld.2014.1121.251.srw.","DOI":"10.15403\/jgld.2014.1121.251.srw"},{"key":"140663r10","doi-asserted-by":"crossref","unstructured":"Tursi A., Papa A., Danese S.: Review article: the pathophysiology and medicalmanagement of diverticulosis and diverticular disease of the colon. AlimentPharmacol. Ther. 2015; 22 July (Epub ahead of print).","DOI":"10.1111\/apt.13322"},{"key":"140663r11","doi-asserted-by":"crossref","unstructured":"Etzioni D.A., Mack T.M., Beart R.W. Jr, Kaiser A.M.: Diverticulitis in theUnited States: 1998\u22122005: changing patterns of disease and treatment. Ann.Surg. 2009; 249: 210\u2212217.","DOI":"10.1097\/SLA.0b013e3181952888"},{"key":"140663r12","doi-asserted-by":"crossref","unstructured":"Krokowicz L., Stojcev Z., Kaczmarek B.F., Kociemba W., Kaczmarek E., WalkowiakJ., Krokowicz P., Drews M., Banasiewicz T.: Microencapsulated sodiumbutyrate administered to patients with diverticulosis decreases incidence ofdiverticulitis \u2212 a\u00a0prospective randomized study. Int. J. Colorectal. Dis. 2014Mar.; 29 (3): 387\u2212393. doi: 10.1007\/s00384-013-1807-5. Epub 2013 Dec 18.","DOI":"10.1007\/s00384-013-1807-5"},{"key":"140663r13","doi-asserted-by":"crossref","unstructured":"Morris C.R., Harvey I.M., Stebbings W.S., Hart A.R.: Incidence of perforateddiverticulitis and risk factors for death in a\u00a0UK population. Br. J. Surg.2008; 95: 876\u2212881.","DOI":"10.1002\/bjs.6226"},{"key":"140663r14","unstructured":"Hinchey E.J., Schaal P.G., Richards G.K.: Treatment of perforated diverticulardisease of the colon. Adv. Surg. 1978; 12: 85\u2212109."},{"key":"140663r15","doi-asserted-by":"crossref","unstructured":"Thornell A., Angenete E., Gonzales E. et al.: Treatment of acute diverticulitislaparoscopic lavage vs. resection (DILALA): study protocol for a\u00a0randomisedcontrolled trial. Trials, 2011; 12: 186.","DOI":"10.1186\/1745-6215-12-186"},{"key":"140663r16","unstructured":"Dziki \u0141., Mik M., Trzcin\u0301ski R., Dziki A.: Leczenie zapalenia uchy\u0142k\u00f3w jelitagrubego \u2013 punkt widzenia chirurga. Gastroenterologia Praktyczna. 2016 (VIII): 3\u22128."},{"key":"140663r17","doi-asserted-by":"crossref","unstructured":"Bauer V.P.: Emergency management of diverticulitis. Clin. Colon. Rectal.Surg. 2009; 22: 161\u2013168.","DOI":"10.1055\/s-0029-1236160"},{"key":"140663r18","unstructured":"Hall J., Hammerich K., Roberts P.: New paradigms in the management ofdiverticular disease. Curr. Probl. Surg., 2010; 47: 680\u2013735."},{"key":"140663r19","doi-asserted-by":"crossref","unstructured":"Alamili M.,\u00a0G\u00f6genur I.,\u00a0Rosenberg J.: Acute complicated\u00a0diverticulitis\u00a0managedby\u00a0laparoscopic lavage.\u00a0Dis. Colon. Rectum.\u00a02009 Jul.;52 (7): 1345\u22121349.doi: 10.1007\/DCR.0b013e3181a0da34.","DOI":"10.1007\/DCR.0b013e3181a0da34"},{"key":"140663r20","doi-asserted-by":"crossref","unstructured":"Bianchi M., Festa V., Moretti A. et al.: Meta-analysis: long term therapywith rifaximin in the management of uncomplicated diverticular disease.Aliment. Pharmacol. Ther. 2011; 33: 902\u2212910.","DOI":"10.1111\/j.1365-2036.2011.04606.x"},{"key":"140663r21","doi-asserted-by":"crossref","unstructured":"Simianu V.V.,\u00a0Fichera A.,\u00a0Bastawrous A.L.,\u00a0Davidson G.H.,\u00a0FlorenceM.G.,\u00a0Thirlby R.C.,\u00a0Flum D.R.:\u00a0Number of Diverticulitis EpisodesBefore Resection and Factors Associated With Earlier Interventions.JAMA Surg. 2016 Jul. 1;151 (7): 604\u2212610. doi: 10.1001\/jamasurg.2015.5478.","DOI":"10.1001\/jamasurg.2015.5478"},{"key":"140663r22","doi-asserted-by":"crossref","unstructured":"Simianu V.V.,\u00a0Strate L.L.,\u00a0Billingham R.P.,\u00a0Fichera A.,\u00a0Steele S.R.,\u00a0ThirlbyR.C.,\u00a0Flum D.R.: The Impact of Elective\u00a0Colon\u00a0Resection on Rates of EmergencySurgery for\u00a0Diverticulitis. Ann. Surg. 2016 Jan.;263 (1):123\u2212129. doi:10.1097\/SLA.0000000000001053.","DOI":"10.1097\/SLA.0000000000001053"},{"key":"140663r23","doi-asserted-by":"crossref","unstructured":"Kruis W., Germer C.T., Leifeld L. (German Society for Gastroenterology,Digestive and Metabolic Diseases and The German Society for Generaland Visceral Surgery): Diverticular disease: guidelines of the german societyfor gastroenterology, digestive and metabolic diseases and the germansociety for general and visceral surgery. Digestion. 2014; 90 (3): 190\u2212207.doi: 10.1159\/000367625. Epub 2014 Nov. 19.","DOI":"10.1159\/000367625"},{"key":"140663r24","doi-asserted-by":"crossref","unstructured":"Mandalia A.,\u00a0Kraft C.S., Dhere T.: Diverticulitis after fecal microbiota\u00a0transplantfor C. difficile infection. Am. J. Gastroenterol.\u00a02014 Dec.;109 (12):1956\u2013 1957 doi: 10.1038\/ajg.2014.350.","DOI":"10.1038\/ajg.2014.350"},{"key":"140663r25","doi-asserted-by":"crossref","unstructured":"Pimentel M.: Review article: potential mechanisms of action of rifaximin inthe management of irritable bowel syndrome with diarrhea. Aliment Pharmacol.Ther. 2016; 43 (Suppl 1): 37\u201349.","DOI":"10.1111\/apt.13437"},{"key":"140663r26","doi-asserted-by":"crossref","unstructured":"Raskin J.B., Kamm M.A., Mazen Jamal M. et al.: Mesalamine did not preventrecurrent diverticulitis in phase 3 controlled trials. Gastroenterol.2014; 147: 793\u2013802 .","DOI":"10.1053\/j.gastro.2014.07.004"}],"container-title":["Polish Journal of Surgery"],"original-title":[],"link":[{"URL":"https:\/\/ppch.pl\/gicid\/pdf\/01.3001.0009.6012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ppch.pl\/gicid\/pdf\/01.3001.0009.6012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T04:57:23Z","timestamp":1571374643000},"score":1,"resource":{"primary":{"URL":"https:\/\/ppch.pl\/gicid\/01.3001.0009.6012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2,28]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0009.6012","relation":{},"ISSN":["0032-373X","2299-2847"],"issn-type":[{"value":"0032-373X","type":"print"},{"value":"2299-2847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}